Cholestyramine Powder, For Suspension
Product Images NDC 42571-508

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cholestyramine (NDC 42571-508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cholestyramine-crtnlbl.jpg (Cholestyramine Crtnlbl)

Cholestyramine-crtnlbl.jpg (Cholestyramine Crtnlbl)
The scanned text is a product description for "Cholestyramine for Oral Suspension, USP." It contains information about the single-dose pouches, the amount of cholestyramine resin per pouch, and mentions that the product contains sucrose. The product is in an orange flavor. It also advises to keep medications out of reach.*
FDA Label Image

Cholestyramine-pouchlbl.jpg (Cholestyramine Pouchlbl)

Cholestyramine-pouchlbl.jpg (Cholestyramine Pouchlbl)
This is a description of a single-dose pack of Cholestyramine for Oral Suspension, USP. Each 9g pouch contains 4g of cholestyramine resin. The powder has an orange flavor and is to be mixed with at least 2 to 6 ounces of water or a beverage of choice for consumption. The usual dosage instructions are provided in the accompanying prescribing information. The product should be stored at 20°C to 25°C but can tolerate excursions between 15°C to 30°C. It is important to keep this medication out of reach of children as it contains sucrose. The product is manufactured by Micro Labs Limited in India and distributed by Micro Labs USA, Inc. in Somerset, NJ.*
FDA Label Image

Cholestyramine-stru (Cholestyramine Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.